Regenerative Aesthetics Brand aphranel® Featured at MXGP Shanghai 2026
MOYOM Biotech's regenerative aesthetics brand, aphranel®, was an official partner at the MXGP Shanghai 2026 event, introducing its approach to facial aesthetics to a broader audience.
MOYOM Biotech's regenerative aesthetics brand, aphranel®, served as an official partner for the 2026 FIM Motocross World Championship (MXGP) Shanghai, held from September 11–13. The event provided a platform for the brand to introduce its approach to facial aesthetics beyond the traditional medical aesthetics community.
The aphranel® exhibition space incorporated the brand's signature green alongside butterfly installations, motorcycles, and motocross displays. Operating as a "Time Café" with the theme "Own Your State. Dare to Take the Stage," the area attracted visitors and became a popular spot for photographs throughout the race weekend.
Given the event's predominantly male audience, aphranel® focused on male facial aesthetics. Its MagiCCrystal CaHA Biostructurer is designed for anatomy-based facial contouring in areas such as the brow, nose, chin, and jawline, emphasizing facial proportion and structural definition.
MagiCCrystal is the outcome of a CaHA development program initiated by MOYOM Biotech in 2013. After 12 years of research and development, the product received NMPA Class III medical device registration in February 2025. Since its commercial launch, cumulative sales have exceeded 200,000 syringes, distributed through over 700 clinics in China. The MXGP partnership allowed aphranel® to connect its long-term research and technical precision with qualities valued in motorsport.